News

Researchers at the University of Illinois Chicago have shown that even after lung tissue has been damaged, it may be possible to reverse fibrosis and promote tissue repair through treatment with microgel-coated mesenchymal stromal cells.

A study will investigate whether it's possible to predict who remains susceptible to SARS-CoV-2 variants after having COVID-19 or receiving a COVID-19-specific vaccine.

A computer scientist has won a grant to develop a new approach to model and analyze protein-ligand interactions in cancer research.

The new method, RApid DIgital Crispr Approach (RADICA), is a molecular testing methodology that allows absolute quantification of viral nucleic acids in 40-60 minutes. It is four times faster and significantly less expensive than conventional polymerase chain reaction methods as it does not require costly equipment for precise temperature control and cycling.

The US Food and Drug Administration today (June 7) announced the results of their investigation into Biogen’s investigational treatment for Alzheimer’s disease (AD), the monoclonal antibody aducanumab. The agency announced that the compound, under the trade name Aduhelm, is to be approved for treatment, via the FDA’s accelerated approval pathway.

The UK Medicines and Healthcare Regulatory Agency (MHRA) has authorized an extension to the UK approval of the Pfizer/BioNTech COVID-19 vaccine (BNT162b2), permitting its use in children aged 12–15.

Researchers have demonstrated a base editing approach that corrects the mutation underlying sickle cell disease in patient blood stem cells.

Scientists have developed the first cells that can construct artificial polymers from building blocks not found in nature.

Researchers have discovered that cepharanthine and nelfinavir are effective at combating SARS-CoV-2, with the former preventing the virus from entering cells and the latter preventing the virus from replicating.

A study shows that one-quarter of people who take methotrexate for common immune system disorders mount a weaker immune response to a COVID-19 vaccine.